Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia. Blood Cancer J. 2019;9(10):1–10.
Article
Google Scholar
Chung YN, Kim H-N, Lee S-R, Sung HJ, Nam M-H. Usefulness of chromosomal microarray in hematologic malignancies: a case of aggressive NK-cell leukemia with 1q abnormality. Lab Med. 2019;9(3):189–93.
Google Scholar
Breccia M, Celant S, Olimpieri PP, Olimpieri OM, Pane F, Iurlo A, Cirilli A, Colatrella A, Gozzo L, Pugliese S. Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA). Ann Hematol. 2021;100(2):481–5.
Article
CAS
PubMed
Google Scholar
Ochi Y, Yoshida K, Huang Y-J, Kuo M-C, Sasaki K, Hosoya N, Hiramoto N, Bera R, Nannya Y, Shiozawa Y. Prognostic relevance of genetic abnormalities in blastic transformation of chronic myeloid leukemia. Blood. 2020;136:3–4.
Article
Google Scholar
Houshmand M, Simonetti G, Circosta P, Gaidano V, Cignetti A, Martinelli G, Saglio G, Gale RP. Chronic myeloid leukemia stem cells. Leukemia. 2019;33(7):1543–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Itonaga H, Ota S, Ikeda T, Taji H, Amano I, Hasegawa Y, Ichinohe T, Fukuda T, Atsuta Y, Tanizawa A. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: a retrospective nationwide study in Japan. Leuk Res. 2018;75:50–7.
Article
PubMed
Google Scholar
Monteso KC, Othman MA, CapeladeMatos RR, NeyGarcia DR, da Rocha MM, de Souza MT, Albagli LF, Liehr T, Land MG, Silva MLM. An original complex rearrangement involving chromosomes 9, 11, and 14, harboring a complex KMT2A gene rearrangement in an infant with mixed-phenotype acute leukemia. J Pediatr Hematol Oncol. 2021;43(3):e371–4.
Article
CAS
PubMed
Google Scholar
Kollmann S, Grundschober E, Maurer B, Warsch W, Grausenburger R, Edlinger L, Huuhtanen J, Lagger S, Hennighausen L, Valent P. Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia. Leukemia. 2019;33(7):1583–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nicolini FE, Dulucq S, Guilhot J, Etienne G, Mahon F-X. The evaluation of residual disease by digital PCR, and TKI duration are critical predictive factors for molecular recurrence after for stopping imatinib first-line in chronic phase CML patients: results of the STIM2 study. Blood. 2018;132:462.
Article
Google Scholar
Taiwo O, Kasali F, Akinyemi I, Kuyoro S, Awodele O, Ogbaro D, Olaniyan T. Stratification of chronic myeloid leukemia cancer dataset into risk groups using four machine learning algorithms with minimal loss function. Afr J Manag Inf Syst. 2019;1:1–18.
Google Scholar
Lynch CM, Abdollahi B, Fuqua JD, de Carlo AR, Bartholomai JA, Balgemann RN, van Berkel VH, Frieboes HB. Prediction of lung cancer patient survival via supervised machine learning classification techniques. Int J Med Inform. 2017;108:1–8.
Article
PubMed
PubMed Central
Google Scholar
Yu L, Huang X, Gale RP, Wang H, Jiang Q. Variables associated with patient-reported symptoms in persons with chronic phase chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy. Medicine. 2019;98(48):e18079.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu L, Jiang Q. Variables associated with patient-reported symptoms in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. Blood. 2017;130:1605.
Google Scholar
Mosquera Orgueira A, Peleteiro Raíndo A, Cid López M, Díaz Arias JÁ, González Pérez MS, Antelo Rodríguez B, Alonso Vence N, Bao Pérez L, Ferreiro Ferro R, Albors Ferreiro M. Personalized survival prediction of patients with acute myeloblastic leukemia using gene expression profiling. Front Oncol. 2021;11:1018.
Article
Google Scholar
Sasaki K, Jabbour EJ, Ravandi F, Konopleva M, Borthakur G, Wierda WG, Daver N, Takahashi K, Naqvi K, DiNardo C. The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: a model to improve patient outcomes. Am J Hematol. 2021;96(2):241–50.
Article
PubMed
Google Scholar
Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A. Predicting survival in patients with advanced disease. Eur J Cancer. 2008;44(8):1146–56.
Article
PubMed
Google Scholar
Simmons CP, McMillan DC, McWilliams K, Sande TA, Fearon KC, Tuck S, Fallon MT, Laird BJ. Prognostic tools in patients with advanced cancer: a systematic review. J Pain Symptom Manag. 2017;53(5):962-970.e910.
Article
Google Scholar
Koteluk O, Wartecki A, Mazurek S, Kołodziejczak I, Mackiewicz A. How do machines learn? Artificial intelligence as a new era in medicine. J Personal Med. 2021;11(1):32.
Article
Google Scholar
Nadarajah R, Wu J, Frangi AF, Hogg D, Cowan C, Gale C. Predicting patient-level new-onset atrial fibrillation from population-based nationwide electronic health records: protocol of FIND-AF for developing a precision medicine prediction model using artificial intelligence. BMJ Open. 2021;11(11):e052887.
Article
PubMed
PubMed Central
Google Scholar
Fontana G. Artificial intelligence and big data in the healthcare sector. The revolution of traditional medicine and the birth of precision therapy. Analysis and evolution of big players in healthcare and new start-ups, growth assumptions, and investment prospects. National and European legislative and regulatory limits. Management. 2020;20:22.
Google Scholar
Hale AT, Stonko DP, Brown A, Lim J, Voce DJ, Gannon SR, Le TM, Shannon CN. Machine-learning analysis outperforms conventional statistical models and CT classification systems in predicting 6-month outcomes in pediatric patients sustaining traumatic brain injury. Neurosurg Focus. 2018;45(5):E2.
Article
PubMed
Google Scholar
Singal AG, Mukherjee A, Elmunzer BJ, Higgins PD, Lok AS, Zhu J, Marrero JA, Waljee AK. Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol. 2013;108(11):1723.
Article
PubMed
PubMed Central
Google Scholar
Jamshidi A, Pelletier J-P, Martel-Pelletier J. Machine-learning-based patient-specific prediction models for knee osteoarthritis. Nat Rev Rheumatol. 2019;15(1):49–60.
Article
PubMed
Google Scholar
Feng Y, Wang X, Zhang J. A heterogeneous ensemble learning method for neuroblastoma survival prediction. IEEE J Biomed Health Inform. 2021;26:1472–83.
Article
Google Scholar
Jayashanka R, Wijesinghe C, Weerasinghe A, Pieris D. Machine learning approach to predict the survival time of childhood acute lymphoblastic leukemia patients. In: 2018 18th international conference on advances in ICT for emerging regions (ICTer): 2018: IEEE; 2018: 426–432.
Shouval R, Ruggeri A, Labopin M, Mohty M, Sanz G, Michel G, Petersen E, Chevallier P, Al-Seraihy A, Milpied N-J. A machine learning based model to predict two-year leukemia free survival in cord blood transplantation for acute leukemia-a data mining study, on Behalf of Eurocord, Cord Blood Committee and the Acute Leukemia Working Party of the EBMT. American Society of Hematology Washington; 2015.
Das AK, Mishra S, Mishra DK, Gopalan SS. Machine learning to predict 5-year survival among pediatric Acute Myeloid Leukemia patients and development of OSPAM-C online survival prediction tool. medRxiv. 2020.
Eckardt J-N, Rollig C, Kramer M, Stasik S, Georgi J-A, Heisig P, Kroschinsky FP, Schetelig J, Platzbecker U, Müller-Tidow C. Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning. Blood. 2021;138:108.
Article
Google Scholar
Hosseini Teshnizi S, Tazhibi M, Tavasoli Farahi M. Comparison of Cox regression and Artificial Neural Network models in prediction of survival in acute leukemia patients. Sci J Iran Blood Transfus Org. 2013;10(2):154–62.
Google Scholar
Karami K, Akbari M, Moradi M-T, Soleymani B, Fallahi H. Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques. PLoS ONE. 2021;16(7):e0254976.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hauser RG, Esserman D, Beste LA, Ong SY, Colomb DG Jr, Bhargava A, Wadia R, Rose MG. A machine learning model to successfully predict future diagnosis of chronic myelogenous leukemia with retrospective electronic health records data. Am J Clin Pathol. 2021;156(6):1142–8.
Article
PubMed
Google Scholar
Zhu S-L, Dong J, Zhang C, Huang Y-B, Pan W. Application of machine learning in the diagnosis of gastric cancer based on noninvasive characteristics. PLoS ONE. 2020;15(12):e0244869.
Article
CAS
PubMed
PubMed Central
Google Scholar
Neeraj KN, Maurya V. A review on machine learning (feature selection, classification and clustering) approaches of big data mining in different area of research. J Crit Rev. 2020;7(19):2610–26.
Google Scholar
Alqudah AM, Al-Hashem M, Alqudah A. Reduced number of parameters for predicting post-stroke activities of daily living using machine learning algorithms on initiating rehabilitation. Informatica. 2021;45(4):571–81.
Article
Google Scholar
Alqudah AM. Ovarian cancer classification using serum proteomic profiling and wavelet features a comparison of machine learning and features selection algorithms. J Clin Eng. 2019;44(4):165–73.
Article
Google Scholar
Al-Hashem MA, Alqudah AM, Qananwah Q. Performance evaluation of different machine learning classification algorithms for disease diagnosis. Int J E-Health Med Commun IJEHMC. 2021;12(6):1–28.
Article
Google Scholar
Gu X, Guo J, Xiao L, Ming T, Li C. A feature selection algorithm based on equal interval division and minimal-redundancy–maximal-relevance. Neural Process Lett. 2020;51(2):1237–63.
Article
Google Scholar
Kashefizadeh A, Ohadi L, Golmohammadi M, Araghi F, Dadkhahfar S, Kiani A, Abedini A, Fadaii A, Ghojoghi A, Nouraie M, et al. Clinical features and short-term outcomes covid-19 in Tehran, Iran: an analysis of mortality and hospital stay. Acta Biomed. 2020;91(4):1–10.
Google Scholar
Chen D, Goyal G, Go R, Parikh S, Ngufor C. Predicting time to first treatment in chronic lymphocytic leukemia using machine learning survival and classification methods. In: 2018 IEEE international conference on healthcare informatics (ICHI): 2018: IEEE; 2018: 407–408.
Hu X, Wang B, Chen Q, Huang A, Fu W, Liu L, Zhang Y, Tang G, Cheng H, Ni X. A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia. J Cancer. 2021;12(16):4912–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coombes CE, Abrams ZB, Li S, Abruzzo LV, Coombes KR. Unsupervised machine learning and prognostic factors of survival in chronic lymphocytic leukemia. J Am Med Inform Assoc. 2020;27(7):1019–27.
Article
PubMed
PubMed Central
Google Scholar